[Depot neuroleptics in indications for tranquilizers: administration forms and risk in neurologic practice].
Schmidt
L G
LG
D003692:Delayed-Action Preparations; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D005260:Female; D005484:Fluspirilene / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*; D011358:Product Surveillance, Postmarketing; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D013141:Spiro Compounds / Q000009:adverse effects*
D003692:Delayed-Action Preparations; D013141:Spiro Compounds; D005484:Fluspirilene
Depot-Neuroleptika in Tranquilizerindikation: Anwendungsformen und Risiken in der nervenärztlichen Praxis.